427 related articles for article (PubMed ID: 8086178)
1. Fibrinolysis during cardiac surgery. Release of tissue plasminogen activator in arterial and coronary sinus blood.
Valen G; Eriksson E; Risberg B; Vaage J
Eur J Cardiothorac Surg; 1994; 8(6):324-30. PubMed ID: 8086178
[TBL] [Abstract][Full Text] [Related]
2. Release of creatine kinase, troponin-T, and tissue plasminogen activator in arterial and coronary venous blood during coronary artery bypass surgery.
Valen G; Owall A; Eriksson E; Kallner A; Risberg B; Vaage J
Scand J Clin Lab Invest; 1997 Feb; 57(1):85-93. PubMed ID: 9127461
[TBL] [Abstract][Full Text] [Related]
3. Studies on oral contraceptive-induced changes in blood coagulation and fibrinolysis and the estrogen effect on endothelial cells.
Quehenberger P; Kapiotis S; Pärtan C; Schneider B; Wenzel R; Gaiger A; Speiser W
Ann Hematol; 1993 Jul; 67(1):33-6. PubMed ID: 8392873
[TBL] [Abstract][Full Text] [Related]
4. The impact of cardiac ischemia and reperfusion on markers of activated haemostasis and fibrinolysis during cardiopulmonary bypass: comparison of plasma levels in arterial and coronary venous blood.
Kalweit G; Bach J; Huwer H; Winning J; Hellstern P
Thromb Res; 2005; 116(1):33-9. PubMed ID: 15850606
[TBL] [Abstract][Full Text] [Related]
5. [Endothelial parameters in blood plasma of patients suffering from ischaemic heart disease and undergoing surgery with extracorporeal circulation].
Rość D; Ogorzeja W; Kotschy M; Missima M; Jurkowski P
Pol Arch Med Wewn; 2004 Nov; 112(5):1297-302. PubMed ID: 15773511
[TBL] [Abstract][Full Text] [Related]
6. Fibrinolysis in patients with acute ischaemic heart disease. With particular reference to systemic effects of tissue-type plasminogen activator treatment on fibrinolysis, coagulation and complement pathways.
Munkvad S
Dan Med Bull; 1993 Sep; 40(4):383-408. PubMed ID: 8222763
[TBL] [Abstract][Full Text] [Related]
7. Systematic elucidation of effects of tranexamic acid on fibrinolysis and bleeding during and after cardiopulmonary bypass surgery.
Kojima T; Gando S; Morimoto Y; Mashio H; Goda Y; Kawahigashi H; Kemmotsu O
Thromb Res; 2001 Dec; 104(5):301-7. PubMed ID: 11738071
[TBL] [Abstract][Full Text] [Related]
8. Secretion of tissue plasminogen activator and plasminogen activator inhibitor 1 during cardiopulmonary bypass.
Chandler WL; Velan T
Thromb Res; 2003; 112(3):185-92. PubMed ID: 14967416
[TBL] [Abstract][Full Text] [Related]
9. [Plasminogen activators (t-PA and u-PA) and other fibrinolysis parameters in patients with atherosclerosis obliterans and diabetic macroangiopathy].
Zalewska-Rydzkowska D; Rość D; Ponikowska I; Michalski A; Graczykowska-Koczorowska A; Rydzkowski M
Pol Merkur Lekarski; 2001 Nov; 11(65):414-7. PubMed ID: 11852811
[TBL] [Abstract][Full Text] [Related]
10. Changes in hemostasis during pediatric heart surgery: impact of a biocompatible heparin-coated perfusion system.
Jensen E; Andréasson S; Bengtsson A; Berggren H; Ekroth R; Larsson LE; Ouchterlony J
Ann Thorac Surg; 2004 Mar; 77(3):962-7. PubMed ID: 14992907
[TBL] [Abstract][Full Text] [Related]
11. Evidence of a net release of tissue-type plasminogen activator across the human cerebral vasculature.
Jern C; Blomstrand C; Westerlind A
Thromb Haemost; 2004 May; 91(5):1019-25. PubMed ID: 15116264
[TBL] [Abstract][Full Text] [Related]
12. Changes in plasminogen activator inhibitor 1 and tissue-type plasminogen activator during exercise in patients with coronary artery disease.
Rydzewski A; Sakata K; Kobayashi A; Yamazaki N; Urano T; Takada Y; Takada A
Haemostasis; 1990; 20(5):305-12. PubMed ID: 2127039
[TBL] [Abstract][Full Text] [Related]
13. Impaired myocardial t-PA release in patients with coronary artery disease.
Osterlund B; Jern S; Jern C; Seeman-Lodding H; Ostman M; Johansson G; Biber B
Acta Anaesthesiol Scand; 2008 Nov; 52(10):1375-84. PubMed ID: 19025531
[TBL] [Abstract][Full Text] [Related]
14. Endothelial tissue-type plasminogen activator release in coronary heart disease: Transient reduction in endothelial fibrinolytic reserve in patients with unstable angina pectoris or acute myocardial infarction.
Hoffmeister HM; Jur M; Ruf-Lehmann M; Helber U; Heller W; Seipel L
J Am Coll Cardiol; 1998 Mar; 31(3):547-51. PubMed ID: 9502633
[TBL] [Abstract][Full Text] [Related]
15. The influence of acute preoperative plasmapheresis on coagulation tests, fibrinolysis, blood loss and transfusion requirements in cardiac surgery.
Menges T; Welters I; Wagner RM; Boldt J; Dapper F; Hempelmann G
Eur J Cardiothorac Surg; 1997 Mar; 11(3):557-63. PubMed ID: 9105824
[TBL] [Abstract][Full Text] [Related]
16. Type 2 Diabetes and Cardiovascular Factors Contrasted with Fibrinolysis Disorders in the Blood of Patients with Peripheral Arterial Disease.
Wieczór R; Wieczór AM; Kulwas A; Rość D
Medicina (Kaunas); 2019 Jul; 55(7):. PubMed ID: 31336615
[No Abstract] [Full Text] [Related]
17. Calcium regulation of tissue plasminogen activator and plasminogen activator inhibitor-1 release from cultured human vascular endothelial cells.
Yamamoto C; Kaji T; Sakamoto M; Kozuka H; Koizumi F
Thromb Res; 1994 Apr; 74(2):163-8. PubMed ID: 8029817
[TBL] [Abstract][Full Text] [Related]
18. Heparin-coated bypass circuits (Carmeda) suppress the release of tissue plasminogen activator during normothermic coronary artery bypass graft surgery.
Spiess BD; Vocelka C; Cochran RP; Soltow L; Chandler WL
J Cardiothorac Vasc Anesth; 1998 Jun; 12(3):299-304. PubMed ID: 9636912
[TBL] [Abstract][Full Text] [Related]
19. Physical exertion induces thrombin formation and fibrin degradation in patients with peripheral atherosclerosis.
Mustonen P; Lepäntalo M; Lassila R
Arterioscler Thromb Vasc Biol; 1998 Feb; 18(2):244-9. PubMed ID: 9484989
[TBL] [Abstract][Full Text] [Related]
20. Alterations in coagulation and fibrinolysis associated with cardiopulmonary bypass during open heart surgery.
Tanaka K; Takao M; Yada I; Yuasa H; Kusagawa M; Deguchi K
J Cardiothorac Anesth; 1989 Apr; 3(2):181-8. PubMed ID: 2535275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
